Accuracy of screening for gastric cancer using serum pepsinogen concentrations - Wikidata - wikimedia - TriplyDB

Accuracy of screening for gastric cancer using serum pepsinogen concentrations

Accuracy of screening for gastric cancer using serum pepsinogen concentrations

http://www.wikidata.org/entity/Q35355212

about

Emerging blood-based biomarkers for detection of gastric cancer Significance of Serum Pepsinogens as a Biomarker for Gastric Cancer and Atrophic Gastritis Screening: A Systematic Review and Meta-Analysis Helicobacter pylori Antibody Titer and Gastric Cancer Screening Gastric cancer: prevention, screening and early diagnosis Potential role of metabolomics in diagnosis and surveillance of gastric cancer Diagnosis and management of high risk group for gastric cancer Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portu Serum trefoil factor 3 is a promising non-invasive biomarker for gastric cancer screening: a monocentric cohort study in China.Non-invasive diagnosis of gastric mucosal atrophy in an asymptomatic population with high prevalence of gastric cancer Metachronous gastric cancer after successful Helicobacter pylori eradication.Serological assessment of gastric mucosal atrophy in gastric cancer.The role of serum pepsinogen in the detection of gastric cancer Correlations among endoscopic, histologic and serologic diagnoses for the assessment of atrophic gastritis.Quantitative assessment model for gastric cancer screening Usefulness of serum pepsinogen levels as a screening test for atrophic gastritis and gastric cancer Accuracy of pepsinogens for early diagnosis of atrophic gastritis and gastric cancer in Iranian population.Temporal changes in serum biomarkers and risk for progression of gastric precancerous lesions: a longitudinal study In vivo gastric mucosal histopathology using endocytoscopy.Predicting the development of gastric cancer from combining Helicobacter pylori antibodies and serum pepsinogen status: a prospective endoscopic cohort study Rationale in diagnosis and screening of atrophic gastritis with stomach-specific plasma biomarkers.A Novel Electrochemical Microfluidic Chip Combined with Multiple Biomarkers for Early Diagnosis of Gastric Cancer.Significance of a novel sucrose permeability test using serum in the diagnosis of early gastric cancer Improvement of reflux symptom related quality of life after Helicobacter pylori eradication therapy.Importance of atrophic gastritis in diagnostics and prevention of gastric cancer: application of plasma biomarkers.Background factors of reflux esophagitis and non-erosive reflux disease: a cross-sectional study of 10,837 subjects in Japan.Serum high mobility group box-1 (HMGB1) is closely associated with the clinical and pathologic features of gastric cancer.Identification of serum miRNAs as novel non-invasive biomarkers for detection of high risk for early gastric cancer.The Serum Pepsinogen Test as a Predictor of Kazakh Gastric Cancer.Review article: methods of measuring gastric acid secretion.Metabolomic studies of human gastric cancer: review Implementation of gastric cancer screening - the global experience.Helicobacter pylori-negative gastric cancer: characteristics and endoscopic findings.Optimal cutoff value of the serum pepsinogen level for prediction of gastric cancer incidence: the Hisayama Study.Novel risk markers for gastric cancer screening: Present status and future prospects.Migrant communities constitute a possible target population for primary prevention of Helicobacter pylori-related complications in low incidence countries.The serum pepsinogen levels for risk assessment of gastric neoplasms: New proposal from a case-control study in Korea.Pepsinogens to Distinguish Patients With Gastric Intestinal Metaplasia and Helicobacter pylori Infection Among Populations at Risk for Gastric Cancer.Pepsinogen-II 100 bp ins/del gene polymorphism and its elevated circulating levels are associated with gastric cancer, particularly with Helicobacter pylori infection and intestinal metaplasia.Simultaneous detection of different serum pepsinogens and its primary application Youden index and Associated Cut-points for Three Ordinal Diagnostic Groups.

P2860

Q26778026-09243475-9E59-4F9C-9917-B8E292620AA0 Q26778122-B7CCBDC6-E400-4886-BC9D-F333328AA633 Q26780322-AB796A30-953F-4763-965F-4A9244F1A69A Q26860418-3CA58A69-8465-4161-B4BA-7D2C4B380D66 Q26991966-AF6445E2-6221-4CE0-BC4B-483D295C723E Q28084323-250B57DE-F81B-419F-A549-BC9CF996E322 Q30426539-325D318D-0B03-4A50-8556-EB849AD3F9A7 Q33574985-15794B72-9F00-4218-A9F9-F1F5C2E05645 Q33867655-0DCF6478-F989-4A08-A9CF-266E5F4F0032 Q34137273-2CAB8A95-9F1B-4847-AB89-BEFF28CA5FD4 Q34145097-15192E32-3316-43A4-8EAF-C88B38089143 Q34206645-5205C1F8-BDED-45B3-A663-53A3F4DA05E6 Q34305478-28BED7FC-8B5A-497B-B3E3-5CB28A728404 Q34605355-20810AEE-26BC-46EB-BE26-E53D01AC3669 Q34666286-13BE7F69-4769-4F4C-BF40-7359F9E73557 Q35065659-4AF363C2-95A4-4ECA-8BED-48AAA37FE5EC Q35162642-2E1056FD-7924-4793-89E7-8606961EF7FA Q35534098-B5642721-DEAA-4D99-91D4-14488FFCD67F Q35597488-392B94D8-D68F-4A16-A6F2-96A74E2BB1FF Q35755917-2582A34B-16C1-40DF-996C-A7FE4727A7E7 Q36363265-765B6DE8-48E1-4A7A-9560-D0FFCEE4976B Q36474459-53E8CF8C-978D-4450-88A1-243A29180DBE Q36670838-15BD08BF-0487-4913-8C41-CCD33BCAF131 Q36693173-4B873DAA-14BD-4C6B-A3C4-60298E5AF609 Q37048686-E8B537D7-60FF-4F44-8F7D-637002975006 Q37222012-EBE59D96-EAE9-4BCC-BD0C-1C3DACE29ED7 Q37279280-47341C1B-0768-4068-8DFD-40C5687512B3 Q37676680-8C714E87-C3CA-4BCD-836B-5F7A83EC97A0 Q37831951-D5BABEC9-0ED8-4D35-B2A7-C8AA4C837BD8 Q38227841-A045E209-C766-4BD5-A491-37A5302876D7 Q38273499-0B041800-E794-4A20-98AA-5D8D797E17CB Q38390680-5A4DB71C-7C7C-411E-BE63-A446EC517EBD Q39639201-5778DFFD-AEA8-467B-897C-A1E993B09A31 Q39800607-94FE4897-E897-4461-AF81-BD05F503E38F Q39840656-8F03C950-594C-4878-B15A-B77785DFD03F Q40116541-3E24BCF1-3089-4E9A-8313-6B9BB702A1F9 Q40605162-698454E4-9015-4A64-B1D7-890C22452370 Q40943310-57D7A06B-FC21-4EF5-9161-460F82935308 Q41366481-468154D2-4DF5-401B-A229-BBE27F71725C Q42161417-1E9C91DE-B3F5-4887-8397-544B15B74B30

P2860

Accuracy of screening for gastric cancer using serum pepsinogen concentrations

http://www.wikidata.org/entity/Q35355212

description

1999 nî lūn-bûn

@nan

1999 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

1999 թվականի մայիսին հրատարակված գիտական հոդված

@hy

1999年の論文

@ja

1999年論文

@yue

1999年論文

@zh-hant

1999年論文

@zh-hk

1999年論文

@zh-mo

1999年論文

@zh-tw

1999年论文

@wuu

name

Accuracy of screening for gastric cancer using serum pepsinogen concentrations

@ast

Accuracy of screening for gastric cancer using serum pepsinogen concentrations

@en

type

label

Accuracy of screening for gastric cancer using serum pepsinogen concentrations

@ast

Accuracy of screening for gastric cancer using serum pepsinogen concentrations

@en

prefLabel

Accuracy of screening for gastric cancer using serum pepsinogen concentrations

@ast

Accuracy of screening for gastric cancer using serum pepsinogen concentrations

@en

P1433

Q35355212-1207B7B9-F883-4DDF-8F58-9F6A76266019

P1476

Q35355212-AE13090E-AC08-4178-8A2E-FDC3A4ED6BD5

P2093

Q35355212-2D14C7DF-D65D-4BF8-B30C-F6088B2B83CD

Q35355212-589B1EEE-540D-4C59-9F12-D0ED33FF5929

Q35355212-59DAD253-218E-48B2-A41E-59FF133D1063

Q35355212-67B9DBA3-2099-4711-973A-6992C4E20E62

Q35355212-DCAE348B-1B02-4594-8209-E1B4C22DADC5

Q35355212-E00BF27F-6DB8-4670-B34E-6F5A7E6B4165

P2860

Q35355212-1D8DD5F8-9E15-44BC-B662-0127832D0E4C

Q35355212-2D3D2882-934F-41DA-BB59-0476E75D2374

Q35355212-4D2DD26D-6676-4AAB-A974-14991A18ADB6

Q35355212-60285BEE-8304-4AB8-A8E9-4F44D1F22816

Q35355212-AD34DE34-E7F3-41F9-8825-C7BDD98CA9F8

P304

Q35355212-25A7129C-0841-4D7F-AED7-E8497F057FB1

P31

Q35355212-D29C6768-4E3D-4C60-9251-CF40E5C16754

P356

Q35355212-5933514A-0943-43BB-8A55-77E4405076F6

P407

Q35355212-F93444D1-58CE-498B-9BDA-C88DEEE486C5

P433

Q35355212-9B6BCA43-476A-41BC-8F93-B34D6F679E3A

P478

Q35355212-84607DA1-DDE7-4F46-96A4-3ECB09317111

P577

Q35355212-60B01BCB-6EEA-4499-AC21-88A72D19AF29

P5875

Q35355212-B8D59356-3097-4D18-8F55-9DD27DB27D88

P698

Q35355212-081A381A-E0BF-41EB-98E0-3268DD204CFA

P932

Q35355212-76F83039-411A-4799-9946-BF918AE17CFD

P356

P1433

P1476

Accuracy of screening for gastric cancer using serum pepsinogen concentrations

@en

P2093

Araki T

http://www.w3.org/2001/XMLSchema#string

Fujino MA

http://www.w3.org/2001/XMLSchema#string

Kitahara F

http://www.w3.org/2001/XMLSchema#string

Kobayashi K

http://www.w3.org/2001/XMLSchema#string

Kojima Y

http://www.w3.org/2001/XMLSchema#string

Sato T

http://www.w3.org/2001/XMLSchema#string

P2860

Tissue and serum pepsinogen I and II in gastric cancer identified using immunohistochemistry and rapid ELISA.

[Clinical significance of the measurement of serum pepsinogen group I and II by enzyme-linked immunosorbent assay]

[Mass screening of stomach neoplasms by serum pepsinogen analysis].

The epidemiology of low serum pepsinogen A levels and an international association with gastric cancer rates. EUROGAST Study Group.

Clinical application of serum pepsinogen I and II levels for mass screening to detect gastric cancer.

P304

693-697

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/GUT.44.5.693

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

44

http://www.w3.org/2001/XMLSchema#string

P577

1999-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

13093471

http://www.w3.org/2001/XMLSchema#string

P698

10205207

http://www.w3.org/2001/XMLSchema#string

P932

1727514

http://www.w3.org/2001/XMLSchema#string